DEPO Financial Facts

Total other income (expense): -6.25M
License and collaborative revenue: 760K
See Full Income Statement

Deferred license revenue, non-current portion: 10.19M
Accounts payable and accrued liabilities: 45.58M
See Full Balance Sheet

DepoMed Inc. (DEPO) Earnings

  |   Expand Research on DEPO
Next EPS Date 3/6/15 *Est. EPS Growth Rate -72.7% *Last Qtr.
Average EPS % Beat Rate +226.3% Revenue Growth Rate +37.3% *Last Qtr.
Average % Move 1-Wk after EPS +1.6% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/5/14 Q314 $0.03-$0.04 +$0.07$51.5M$41.5M Details
8/6/14 Q214 -$0.01-$0.08 +$0.07$67.7M$38.03M Details
5/8/14 Q114 $0.30$0.10 +$0.20$76.54M$53.57M Details
3/6/14 Q413 $0.72-$0.21 +$0.93$18.79M$19.06M Details
11/5/13 Q313 $0.11$0.07 +$0.04$37.5M$35.55M = Details
8/7/13 Q213 $0.01-$0.05 +$0.06$30M$29.87M = Details
5/8/13 Q113 -$0.10-$0.06 -$0.04$26.2M$28.93M = Details
2/20/13 Q412 -$0.07-$0.11 +$0.04$26.6M$26.48M = Details